Showing posts with label Legalization of Marijuana. Show all posts
Showing posts with label Legalization of Marijuana. Show all posts

Friday, July 18, 2025

Cannabis Use and Epigenetic Changes: Emerging Scientific Insights

Cannabis Use and Epigenetic Changes: Emerging Scientific Insights

Cannabis, one of the most widely used psychoactive substances globally, has garnered significant attention in recent years due to its legalization in various regions and its potential therapeutic applications. However, alongside its growing acceptance, concerns about its long-term effects on human health, particularly at the molecular level, have prompted rigorous scientific investigation. Recent research has revealed that cannabis use is associated with epigenetic changes—modifications to gene expression that do not involve alterations to the underlying DNA sequence. These findings have profound implications for understanding the biological impact of cannabis use and its potential intergenerational effects. This essay explores the evidence linking cannabis use to epigenetic changes, the mechanisms involved, and the broader implications for public health, drawing on recent scientific literature. Epigenetic Modifications: A Brief Overview Epigenetics refers to heritable changes in gene expression that occur without altering the DNA sequence itself. These changes are mediated by mechanisms such as DNA methylation, histone modification, and non-coding RNA regulation, which collectively influence how genes are activated or silenced (Moore et al., 2013). DNA methylation, in particular, involves the addition of methyl groups to cytosine bases in DNA, often suppressing gene expression. Epigenetic modifications are dynamic, influenced by environmental factors such as diet, stress, and substance use, including cannabis (Feinberg, 2018). Given cannabis’s psychoactive properties and its interaction with the endocannabinoid system, researchers have hypothesized that its use could induce epigenetic changes with lasting effects on cellular function and health. Evidence Linking Cannabis Use to Epigenetic Changes Recent studies have provided compelling evidence that cannabis use is associated with alterations in DNA methylation patterns. A landmark study by Schrott et al. (2021) investigated the epigenetic effects of cannabis use in humans and animal models, focusing on DNA methylation in sperm. The researchers found that cannabis users exhibited significant differences in DNA methylation at multiple genomic loci compared to non-users. These changes were particularly pronounced in genes related to neurodevelopment and immune function, suggesting that cannabis use may influence biological processes critical to brain health and immune response (Schrott et al., 2021). Furthermore, the study identified similar methylation patterns in the sperm of rats exposed to tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, indicating a potential conservation of epigenetic effects across species. Another study by Osborne et al. (2020) explored the impact of cannabis use on epigenetic aging, a measure of biological age derived from DNA methylation patterns. The researchers found that chronic cannabis users exhibited accelerated epigenetic aging compared to non-users, as measured by the Horvath epigenetic clock (Osborne et al., 2020). This finding suggests that cannabis use may contribute to premature cellular aging, potentially increasing the risk of age-related diseases. While the precise mechanisms underlying these changes remain under investigation, the interaction between THC and cannabinoid receptors in the brain and peripheral tissues is thought to play a central role in modulating epigenetic processes (DiNieri et al., 2011). Mechanisms of Cannabis-Induced Epigenetic Changes The endocannabinoid system, which includes cannabinoid receptors (CB1 and CB2), is a key mediator of cannabis’s physiological effects. THC binds to CB1 receptors in the brain, altering neurotransmitter release and influencing gene expression through downstream signaling pathways (Pertwee, 2008). These pathways, including the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) cascades, can modulate epigenetic machinery, such as DNA methyltransferases and histone deacetylases (D’Addario et al., 2013). For instance, chronic THC exposure has been shown to alter histone acetylation in the hippocampus, a brain region critical for memory and learning, potentially contributing to cognitive impairments observed in long-term cannabis users (Prini et al., 2018). Moreover, cannabis use may induce oxidative stress and inflammation, both of which are known to influence epigenetic modifications (Feinberg, 2018). Oxidative stress can disrupt DNA methylation by altering the availability of methyl donors, such as S-adenosylmethionine (SAM), while inflammation may upregulate enzymes that modify histone proteins (Moore et al., 2013). These molecular changes provide a plausible mechanism by which cannabis use could lead to persistent epigenetic alterations, potentially affecting not only the user but also their offspring through transgenerational epigenetic inheritance (Schrott et al., 2021). Implications for Public Health and Future Research The discovery of cannabis-associated epigenetic changes raises important considerations for public health, particularly in the context of increasing cannabis legalization and use. Epigenetic modifications in sperm, as observed by Schrott et al. (2021), suggest that cannabis use may have intergenerational effects, potentially influencing the health and development of offspring. For example, altered methylation in neurodevelopmental genes could increase the risk of neurodevelopmental disorders in children of cannabis users, a hypothesis that warrants further investigation. Similarly, the accelerated epigenetic aging reported by Osborne et al. (2020) underscores the need to assess the long-term health risks of chronic cannabis use, particularly in relation to cardiovascular and neurodegenerative diseases. Despite these findings, significant gaps in knowledge remain. The reversibility of cannabis-induced epigenetic changes, the dose-response relationship, and the impact of different cannabis constituents (e.g., THC vs. cannabidiol) are areas that require further exploration. Longitudinal studies are needed to determine whether these epigenetic changes persist after cessation of cannabis use and to elucidate their clinical significance. Additionally, research should investigate the role of environmental and lifestyle factors, such as diet and stress, in modulating cannabis-related epigenetic effects. Conclusion Emerging evidence suggests that cannabis use is linked to epigenetic changes, particularly in DNA methylation patterns, with potential implications for neurodevelopment, immune function, and biological aging. These findings highlight the complex interplay between cannabis, the endocannabinoid system, and epigenetic regulation, underscoring the need for caution in the context of widespread cannabis use. While current research provides valuable insights, further studies are essential to fully understand the scope and reversibility of these epigenetic changes and their impact on individual and public health. As cannabis legalization continues to expand, integrating these scientific findings into public health policy and education will be critical to promoting informed decision-making and mitigating potential risks.




### References D’Addario, C., DiNieri, J. A., & Hurd, Y. L. (2013). Epigenetic regulation of gene expression in the brain by drugs of abuse. *Neuropsychopharmacology*, 38(1), 167–183. https://doi.org/10.1038/npp.2012.167 DiNieri, J. A., Wang, X., Szutorisz, H., Spano, S. M., Kaur, J., Casaccia, P., ... & Hurd, Y. L. (2011). Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. *Biological Psychiatry*, 70(8), 763–769. https://doi.org/10.1016/j.biopsych.2011.06.007 Feinberg, A. P. (2018). The key role of epigenetics in human disease prevention and mitigation. *New England Journal of Medicine*, 378(14), 1323–1334. https://doi.org/10.1056/NEJMra1402513 Moore, L. D., Le, T., & Fan, G. (2013). DNA methylation and its basic function. *Neuropsychopharmacology*, 38(1), 23–38. https://doi.org/10.1038/npp.2012.112 Osborne, A. J., Pearson, J. F., Noble, A. J., Gemmell, N. J., & Horwood, L. J. (2020). Cannabis use and epigenetic aging: Evidence from the Christchurch Health and Development Study. *Drug and Alcohol Dependence*, 216, 108228. https://doi.org/10.1016/j.drugalcdep.2020.108228 Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. *British Journal of Pharmacology*, 153(2), 199–215. https://doi.org/10.1038/sj.bjp.0707442 Prini, P., Rusconi, F., Zamberletti, E., Gabaglio, M., Penna, F., Fasano, M., ... & Rubino, T. (2018). Adolescent THC exposure causes enduring prefrontal cortical disruption of GABAergic inhibition and dysregulation of sub-cortical dopamine function. *Scientific Reports*, 8(1), 1–13. https://doi.org/10.1038/s41598-018-34329-4 Schrott, R., Acharya, K., Iturra-Mena, A. M., Diwadkar, A., Hurd, Y. L., & Murphy, S. K. (2021). Cannabis use is associated with differential methylation in human sperm. *Epigenetics*, 16(7), 757–767. https://doi.org/10.1080/15592294.2020.1827722

Monday, May 5, 2025

Heavy Cannabis Use and Colon Cancer: A Sobering New Study

Heavy Cannabis Use and Colon Cancer: A Sobering New Study

Recent research has sparked a heated debate about the risks of marijuana use, particularly for those battling serious illnesses like colon cancer. A study published on April 28, 2025, by researchers at the University of California San Diego School of Medicine found a striking correlation: colon cancer patients with a history of high cannabis use were more than 20 times more likely to die within five years of diagnosis compared to those without such a history. This finding, while alarming, raises important questions about cannabis’s impact on cancer outcomes and underscores the need for more research. Let’s dive into the details of the study, explore its implications, and consider the broader context of cannabis and cancer.
The Study: What the Researchers Found
The UC San Diego team analyzed electronic health records from over 1,000 colon cancer patients treated across the University of California Health system between 2012 and 2024. They focused on patients’ documented cannabis use prior to their cancer diagnosis, specifically those with a history of cannabis use disorder (CUD)—a clinical diagnosis indicating problematic, heavy use. After controlling for factors like age, sex, tumor staging, and cancer biomarkers, the results were stark: patients with CUD had a 56% chance of dying within five years, compared to just 5% for those without CUD. This translates to a 24-fold increased risk of mortality for heavy cannabis users.
Lead author Raphael Cuomo, an associate professor at UC San Diego’s Department of Anesthesiology, pointed out that heavy cannabis use may affect the immune system, mental health, and treatment behaviors—all of which could influence cancer outcomes. For instance, high cannabis use is often linked to depression and anxiety, which might hinder a patient’s ability to fully engage with their cancer treatment. The study suggests that these factors, rather than a direct biological effect of cannabis on cancer cells, may be driving the increased mortality risk.
The Context: Cannabis and Cancer Research
This study adds a new layer to the complex relationship between cannabis and cancer. On one hand, some research has suggested potential benefits. A 2019 study from Penn State College of Medicine found that certain synthetic cannabinoid compounds inhibited the growth of colon cancer cells in lab tests. Another 2020 study in mice showed that tetrahydrocannabinol (THC), the psychoactive compound in cannabis, could reduce inflammation and prevent colon cancer linked to ulcerative colitis by binding to cannabinoid receptor type 2 (CB2). These findings have fueled hope that cannabis might one day play a role in cancer treatment or prevention.
However, the UC San Diego study highlights a different side of the story. While lab studies show promise, real-world use of cannabis is far more complicated. The researchers noted that the high concentrations of DMS and DMDS detected on K2-18b, mentioned in a previous post, are thousands of times higher than on Earth, where they are produced by marine life. This comparison, while unrelated to cannabis, illustrates how context matters when interpreting chemical or biological effects. Similarly, the effects of cannabis on colon cancer patients may depend on usage patterns, individual health factors, and the presence of other conditions like mental health challenges.
A Critical Look: What’s Missing?
While the UC San Diego study is compelling, it’s not without limitations. First, it relies on retrospective data, meaning it can’t prove that cannabis use directly caused the higher mortality rates—it only shows an association. Patients with CUD might have other risk factors, like poor overall health or socioeconomic barriers, that weren’t fully accounted for. Second, the study doesn’t explore the mechanisms behind the increased mortality. Does cannabis weaken the immune system’s ability to fight cancer? Does it interfere with chemotherapy? Or is the issue more behavioral, with heavy users less likely to adhere to treatment plans? These questions remain unanswered.
Moreover, the study’s focus on heavy cannabis use—specifically CUD—means its findings may not apply to moderate or occasional users. A 2019 systematic review found no clear association between marijuana use and the development of colorectal cancer, though it noted increased risks for other cancers like testicular cancer among heavy users. This suggests that the risks may be dose-dependent, a nuance the UC San Diego study doesn’t fully address.
It’s also worth questioning the narrative around cannabis. The study has been widely shared on platforms like X, with posts framing it as a warning against marijuana use. Yet, this risks oversimplifying the issue. Cannabis isn’t a monolith—its effects vary depending on the strain, method of use, and individual factors. Vilifying cannabis outright, as some reactions suggest, ignores its potential benefits for symptom management, as noted by colorectal cancer survivors in a 2021 Fred Hutchinson Cancer Center study. Up to 40% of cancer patients report using cannabis to relieve symptoms like nausea and pain, often with positive outcomes.
Implications and the Path Forward
The UC San Diego study doesn’t claim cannabis causes colon cancer or directly worsens it. Instead, it highlights a concerning correlation that demands further investigation. With cannabis use on the rise—4.5 million young adults in the U.S. reported daily or near-daily use in 2023, according to the National Survey on Drug Use and Health—the stakes are high. This is especially true for medically vulnerable populations like cancer patients, who may turn to cannabis for relief but could inadvertently face risks if their use becomes heavy.
For patients, this study underscores the importance of open conversations with healthcare providers. If you’re a colon cancer patient considering cannabis, discuss your usage patterns with your oncology team. For researchers, the study is a call to action. We need prospective studies to track cannabis use before and after a cancer diagnosis, as well as research into the biological pathways—like immune system effects—that might explain these outcomes.
Conclusion: A Balanced Perspective
The UC San Diego study is a sobering reminder that cannabis, despite its growing acceptance, isn’t risk-free—especially for those with serious illnesses like colon cancer. Heavy use may be linked to worse outcomes, but the why and how remain unclear. At the same time, dismissing cannabis entirely ignores its potential benefits for symptom relief and even cancer prevention, as other studies suggest. The truth likely lies in the middle: cannabis can be both a help and a hindrance, depending on how it’s used and by whom. As we await more research, the best approach is caution, curiosity, and honest dialogue—both in the doctor’s office and in the public square.

Sources
  • University of California San Diego School of Medicine, April 28, 2025, published in Annals of Epidemiology.
  • Penn State College of Medicine, 2019, published in Cannabis and Cannabinoid Research.
  • Medical News Today, October 3, 2020, study on THC and colon cancer in mice.
  • National Survey on Drug Use and Health, 2023 data on cannabis use among young adults.
  • Fred Hutchinson Cancer Center, 2021, study on cannabis use among colorectal cancer survivors, published in Cancer Causes & Control.
  • Systematic review on marijuana use and cancer risk, 2019, published in Cancer Epidemiology, Biomarkers & Prevention.

Sacerdotus TV LIveStream

Labels

Catholic Church (1646) Jesus (766) God (755) Bible (622) Atheism (400) Jesus Christ (378) Pope Francis (347) Liturgy of the Word (326) Apologetics (301) Atheist (280) Science (239) Christianity (203) Theology (152) LGBT (148) Liturgy (139) Blessed Virgin Mary (129) Prayer (99) Abortion (97) Gay (95) Philosophy (93) Pope Benedict XVI (93) Traditionalists (84) Rosa Rubicondior (82) Vatican (77) Psychology (75) Physics (74) Christmas (64) New York City (62) Holy Eucharist (61) Christian (60) President Obama (59) Protestant (53) Vatican II (51) Health (49) Biology (48) Gospel (47) Politics (47) Women (44) Racism (40) Supreme Court (35) Baseball (34) Death (34) Pope John Paul II (33) Illegal Immigrants (32) NYPD (32) priests (32) Priesthood (29) Morality (28) Space (28) Astrophysics (27) Eucharist (27) Jewish (27) Religious Freedom (27) Donald Trump (25) Evangelization (25) Christ (22) Evil (22) First Amendment (21) Pro Abortion (19) Child Abuse (17) Divine Mercy (17) Marriage (17) Pedophilia (17) Pro Choice (17) Easter Sunday (16) Holy Trinity (16) Police (16) Pentecostals (15) Sacraments (15) Angels (14) Autism (14) Gender Theory (14) Poverty (13) September 11 (13) Blog (12) CUNY (12) Cognitive Psychology (12) Muslims (12) academia (12) Hispanics (11) Pope Paul VI (11) Evangelicals (10) Massimo Pigliucci (10) Personhood (10) Evidence (9) Hell (9) Podcast (9) Barack Obama (8) Big Bang Theory (8) Human Rights (8) Humanism (8) Condoms (7) David Viviano (7) Death penalty (7) Eastern Orthodox (7) Ellif_dwulfe (7) NY Yankees (7) Spiritual Life (7) Encyclical (6) Gender Dysphoria Disorder (6) Babies (5) Baby Jesus (5) Catholic Bloggers (5) Cyber Bullying (5) Donations (5) Pope Pius XII (5) The Walking Dead (5) Ephebophilia (4) Plenary Indulgence (4) Pluto (4) Pope John XXIII (4) Founding Fathers (3) Dan Arel (2) Freeatheism (2) Oxfam (2) Penn Jillette (2) Pew Research Center (2) Cursillo (1) Dan Savage (1) Divine Providence (1) Fear The Walking Dead (1) Pentecostales (1)